Chartwell Investment Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-12,803	Closed	-$1.16M	–	414
2017 Q2	$1.16M	Buy	12,803 +325	+3%	+$29.6K	0.04%	344
2017 Q1	$1.09M	Sell	12,478 -71,882	-85%	-$6.39M	0.04%	340
2016 Q4	$6.99M	Sell	84,360 -535,265	-86%	-$46M	0.24%	151
2016 Q3	$57.3M	Buy	+619,625	New	+$58.3M	1.02%	20
2016 Q2	–	Sell	-146,547	Closed	-$12.1M	–	402
2016 Q1	$12.1M	Sell	146,547 -15,978	-10%	-$1.3M	0.23%	120
2015 Q4	$17M	Sell	162,525 -127,745	-44%	-$13.3M	0.35%	80
2015 Q3	$30.6M	Buy	290,270 +55,570	+24%	+$7.42M	0.66%	38
2015 Q2	$32.1M	Sell	234,700 -148,775	-39%	-$18.4M	0.63%	45
2015 Q1	$47.8M	Buy	383,475 +258,685	+207%	+$27.4M	0.93%	21
2014 Q4	$11.3M	Sell	124,790 -126,380	-50%	-$10.5M	0.24%	180
2014 Q3	$18.1M	Sell	251,170 -1,950	-0.8%	-$128K	0.41%	74
2014 Q2	$15.7M	Buy	253,120 +32,500	+15%	+$1.96M	0.33%	126
2014 Q1	$15M	Buy	220,620 +36,100	+20%	+$2.66M	0.31%	137
2013 Q4	$13M	Buy	184,520 +2,795	+2%	+$190K	0.27%	163
2013 Q3	$13.1M	Sell	181,725 -53,900	-23%	-$3.58M	0.3%	150
2013 Q2	$13.1M	Buy	+235,625	New	+$14.7M	0.33%	122